Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trialsPaul E. Sax, David A. Wohl, Chloe Orkin et al.|EClinicalMedicine|2023Cited by 90
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept studyJoseph J. Eron, Marina Caskey, Susan J. Little et al.|The Lancet HIV|2024Cited by 47
Research advances in imaging markers for predicting hematoma expansion in intracerebral hemorrhage: a narrative reviewYongwei Huang, Xiao-Shuang Yin, Hailin Huang et al.|Frontiers in Neurology|2023Cited by 20